Tai Chi,Breast cancer,Feasibility study,Randomized controlled trial,Peer support,Health education ," />

Tai Chi,Breast cancer,Feasibility study,Randomized controlled trial,Peer support,Health education ,"/>

Tai Chi,Breast cancer,Feasibility study,Randomized controlled trial,Peer support,Health education ,"/> An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy: Study protocol for a randomized controlled feasibility study

Search JIM Advanced Search

Journal of Integrative Medicine ›› 2018, Vol. 16 ›› Issue (2): 99-105.doi: 10.1016/j.joim.2017.12.011

• Study Protocol • Previous Articles     Next Articles

An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy: Study protocol for a randomized controlled feasibility study

Lizhou Liu a, Simone Petrich b, Blair McLaren c, Lyndell Kelly c, G. David Baxter a   

  1. a Centre for Health, Activity and Rehabilitation Research, School of Physiotherapy, University of Otago, Dunedin 9054, New Zealand
    b Department of Surgical Sciences, Southern District Health Board, Dunedin 9016, New Zealand
    c Oncology Department, Southern District Health Board, Dunedin 9016, New Zealand

  • Received:2017-09-28 Accepted:2017-12-18 Online:2018-03-10 Published:2018-01-31
  • Contact: Lizhou Liu; E-mail: lizhou.liu@otago.ac.nz
  • Supported by:
    This study is funded by the Breast Cancer Foundation New Zealand, the support of which is gratefully acknowledged. This funding source has no role in this study other than providing funding support. LL is funded as the Breast Cancer Foundation New Zealand Belinda Scott Clinical Fellowship 2017.

Background
Breast cancer patients experience various side effects during cancer therapy, often resulting in reduced quality of life and poor adherence to treatment. A limited range of proven interventions has been developed to target such side effects. While Tai Chi offers benefits for the health and well-being of breast cancer survivors, the effectiveness of Tai Chi across the treatment continuum has not been evaluated. Improved patient education and support has been suggested as a priority for breast cancer care. This pilot study assesses the feasibility of a randomized controlled trial (RCT) to evaluate the effectiveness of “an integrative Tai Chi” (ANITA) program for breast cancer patients undergoing cancer therapy.


Methods/design

This is a single-centre, two-arm feasibility RCT. Twenty-four patients with breast cancer who have undergone surgical treatment will be recruited from the Dunedin Hospital (New Zealand) over a 12-month period (from August 2017 to July 2018). Subject to informed consent, patients will be randomized to receive standard cancer treatment alone or standard cancer treatment plus the ANITA program, consisting of peer support, health education, and Tai Chi Ruler exercise. The program runs alongside the patient’s adjuvant cancer therapy, which may include chemotherapy, radiation therapy, antibody treatment, and/or antihormonal therapy. Analysis in this study will focus on process evaluation of participant recruitment, retention, treatment fidelity, acceptability of the program, and occurrence of adverse events. Clinical outcomes (i.e., fatigue, sleep quality, anxiety and depression and quality of life) will be assessed at baseline, and at 12?weeks and 24?weeks post-randomization.


Discussion

Outcomes from this study will inform the feasibility and methodology for a future fully-powered RCT.


Trial registration

Australian New Zealand Clinical Trials Registry with the identifier ACTRN12617000975392.

Key words:

Tai Chi')">

Tai Chi, Breast cancer, Feasibility study, Randomized controlled trial, Peer support, Health education

[1] Carlos R. Oliveira, Daniel G. Spindola, Daniel M. Garcia, Adolfo Erustes, Alexandre Bechara, Caroline Palmeira-dos-Santos, Soraya S. Smaili, Gustavo J.S. Pereira, André Hinsberger, Ezequiel P. Viriato, Maria Cristina Marcucci, Alexandra C.H.F. Sawaya, Samantha L. Tomaz, Elaine G. Rodrigues, Claudia Bincoletto. Medicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor development. Journal of Integrative Medicine, 2019, 17(2): 132-140.
[2] Gloria Gronowicz, Eric R. Secor Jr., John R. Flynn, Liisa T. Kuhn. Human biofield therapy does not affect tumor size but modulates immune responses in a mouse model for breast cancer. Journal of Integrative Medicine, 2016, 14(5): 389-399.
[3] Claudia Maria Sous, Mario Goncalves, Jorge Machado, Thomas Efferth, Tobias Greten , Petra Froeschen , Henry J. Greten. Effects of qigong on performance-related anxiety and physiological stress functions in transverse flute music schoolchildren: A feasibility study. Journal of Chinese Integrative Medicine, 2012, 10(8): 858-865.
[4] Mei-qun Cao, Zheng-zhi Wu, Wei-kang Wu. Identification of salivary biomarkers in breast cancer patients with thick white or thick yellow tongue fur using isobaric tags for relative and absolute quantitative proteomics. Journal of Chinese Integrative Medicine, 2011, 9(3): 275-280.
[5] Mei-na Ye, Hong-feng Chen, Rui-juan Zhou, Ming-juan Liao. Effects of Astragalus polysaccharide on proliferation and Akt phosphorylation of the basal-like breast cancer cell line. Journal of Chinese Integrative Medicine, 2011, 9(12): 1339-1346.
[6] Ying Deng , Hong-feng Chen. Effects of Astragalus injection and its ingredients on proliferation and Akt phosphorylation of breast cancer cell lines. Journal of Chinese Integrative Medicine, 2009, 7(12): 1174-1180.
[7] Mei-na Ye, Hong-feng Chen. Effects of Astragalus injection on proliferation of basal-like breast cancer cell line MDA-MB-468. Journal of Chinese Integrative Medicine, 2008, 6(4): 399-403.
[8] Sheng Liu, Jing Zhao, Jia Liu, Zhen-ping Sun, Yong-qiang Hua, De-ming Lu, Han-jun Tang. Effects of Ru'ai Shuhou Recipe on 5-year recurrence rate after mastectomy in breast cancer. Journal of Chinese Integrative Medicine, 2008, 6(10): 1000-1004.
[9] Sheng Liu, Yong-qiang Hua, Zhen-ping Sun, Song Tan, De-ming Lu. Breast cancer pathogenesis of stagnation of phlegm, poison and blood stasis: rationale and clinical application in traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2007, 5(2): 122-125.
[10] Sheng Liu, Yong-qiang Hua, Zhen-ping Sun, Song Tan, De-ming Lu. Clinical observation of Ruyiping in preventing recidivation and metastasis of breast cancer. Journal of Chinese Integrative Medicine, 2007, 5(2): 147-149.
[11] Sheng-fang Hu, Hong-feng Chen, Qian-wen Rong. Assessing breast cancer risk in women with mammary hyperplasia of different syndromes using mammography. Journal of Chinese Integrative Medicine, 2007, 5(2): 195-.
[12] TANG Xin. Experience of Professor Han-jun Tang in treating breast cancer after operation based on syndrome differentiation. Journal of Chinese Integrative Medicine, 2007, 5(2): 201-203.
[13] Xiu-fei Gao, Sheng Liu. Influencing factors and psychotherapies of psychogenic problems in breast cancer patients. Journal of Chinese Integrative Medicine, 2007, 5(2): 213-215.
[14] Yi Lin, Qian-jun Chen, Peng-xi Liu. Standardization of syndrome differentiation based on stages for breast cancer: a significant and updating topic on mastology of traditional Chinese medicine. Journal of Chinese Integrative Medicine, 2006, 4(5): 447-450.
[15] Sheng Liu​, Xiao-hong Xue​, Xin-wei Yang​, De-ming Lu​. Effects of Runing Recipe medicated serum on expressions of genes in breast cancer cells. Journal of Chinese Integrative Medicine, 2006, 4(5): 490-494.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[2] Dong Yang, Yong-ping Du, Qing Shen, Wei Chen, Yan Yu, Guang-lei Chen. Expression of alpha-smooth muscle actin in renal tubulointerstitium in patients with kidney collateral stasis. Journal of Chinese Integrative Medicine, 2008, 6(1): 41-44
[3] Xi Lin, Jian-ping Liu. Tai chi for treating rheumatoid arthritis. Journal of Chinese Integrative Medicine, 2008, 6(1): 82
[4] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[5] Ning-qun Wang, Liang-duo Jiang, Zong-xing Li. Research progress in asthma-related quality of life. Journal of Chinese Integrative Medicine, 2008, 6(1): 93-97
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047
[9] Ya-hui Liang , Ping Li, Jing-xia Zhao, Xin Liu, Qi-fu Huang. Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1. Journal of Chinese Integrative Medicine, 2010, 8(11): 1060-1069
[10] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074